A drug already widely used in massive campaigns to help control two parasitic diseases river blindness and elephantiasis could also drive down malaria a new study has found.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa.